Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EUCAST Determination of Olorofim (F901318) Susceptibility of Mold Species, Method Validation, and MICs

16 May 2018

Abstract excerpt

ABSTRACT Olorofim is a novel antifungal agent with in vitro activity against Aspergillus and some other molds. Here, we addressed technical aspects for EUCAST olorofim testing and generated contemporary MIC data. EUCAST E.Def 9.3.1 testing was performed comparing two plate preparation methods (serial dilution in medium [serial plates] versus predilution in DMSO [ISO plates]), two lots of olorofim, visual...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal resistance and susceptibility

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 29784842
DOI: 10.1128/aac.00487-18

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EUCAST Determination of Olorofim (F901318) Susceptibility of Mold Species, Method Validation, and MICsPMID 29784842Read ↗

Identification and antifungal susceptibility patterns of reference yeast strains to novel and conventional agents: a comparative study using CLSI, EUCAST and Sensititre YeastOne methodsSemantic proximity Read ↗

Spectrophotometric reading of EUCAST antifungal susceptibility testing of Aspergillus fumigatus.Semantic proximity Read ↗

Resistance profiling of Aspergillus fumigatus to olorofim indicates absence of intrinsic resistance and unveils the molecular mechanisms of acquired olorofim resistanceSemantic proximity Read ↗

EUCAST Susceptibility Testing of Isavuconazole: MIC Data for Contemporary Clinical Mold and Yeast IsolatesSemantic proximity Read ↗

Novel Antifungals and <em>Aspergillus</em> Section <em>Terrei</em> with Potpourri Susceptibility Profiles to Conventional AntifungalsSemantic proximity Read ↗

Resistance profiling of <i>Aspergillus fumigatus</i> to olorofim indicates absence of intrinsic resistance and unveils the molecular mechanisms of acquired olorofim resistanceSemantic proximity Read ↗

Potency of Olorofim (F901318) Compared to Contemporary Antifungal Agents against Clinical Aspergillus fumigatus Isolates and Review of Azole Resistance Phenotype and Genotype Epidemiology in ChinaSemantic proximity Read ↗

Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST method.Semantic proximity Read ↗

Phylogenetic Insights into Antifungal Susceptibility: Comparing Environmental and Clinical <i>Scedosporium</i> and <i>Lomentospora</i> Isolates from TaiwanSemantic proximity Read ↗

Twenty Years in EUCAST Anti-Fungal Susceptibility Testing: Progress & Remaining ChallengesSemantic proximity Read ↗

Antifungal Susceptibility Profiles of Olorofim (Formerly F901318) and Currently Available Systemic Antifungals against Mold and Yeast Phases of Talaromyces marneffeiSemantic proximity Read ↗

Aspergillus Section Terrei and Antifungals: From Broth to Agar-Based Susceptibility Testing MethodsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.